Page 256 - The Netter Collection of Medical Illustrations - Integumentary System_ Volume 4 ( PDFDrive )
P. 256
References Integumentary System
Zalaudek I, Hofmann-Wellenhof R, Kittler H, et al. A dual concept Kossard S, Tan KB, Choy C. Keratoacanthoma and infundibulo- Alikhan A, Kurek L, Feldman SR. The role of tetracyclines in
of nevogenesis: theoretical considerations based on dermoscopic cystic squamous cell carcinoma. Am J Dermatopathol. 2008;30: rosacea. Am J Clin Dermatol. 2010;11:79-87.
features of melanocytic nevi. J Dtsch Dermatol Ges. 2007;5: 127-134. Al-Mahfoudh R, Clark S, Buxton N. Alkaptonuria presenting
985-992. Lansigan F, Foss FM. Current and emerging treatment strategies with ochronotic spondyloarthropathy. Br J Neurosurg. 2008;22:
Zarineh A, Kozovska ME, Brown WG, et al. Smooth muscle ham- for cutaneous T-cell lymphoma. Drugs. 2010;70:273-286. 805-807.
artoma associated with a congenital pattern of melanocytic nevus: Liao PB. Merkel cell carcinoma. Dermatol Ther. 2008;21:447-451. Antoniu SA. Targeting the TNF-alpha pathway in sarcoidosis.
a case report and review of the literature. J Cutan Pathol. Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in Expert Opin Ther Targets. 2010;14:21-29.
2008;35:83-86. patients with metastatic carcinoma: a retrospective study of 4020 Aractingi S, Chosidow O. Cutaneous graft-versus-host disease.
patients. J Am Acad Dermatol. 1993;29:228-236. Arch Dermatol. 1998;134:602-612.
Section 3: Malignant Growths Mendenhall WM, Mendenhall CM, Werning JW, et al. Cutaneous Araki K, Sudo A, Hasegawa M, et al. Devastating ochronotic
Abrams TA, Schuetze SM. Targeted therapy for dermatofibrosar- angiosarcoma. Am J Clin Oncol. 2006;29:524-528. arthropathy with successful bilateral hip and knee arthroplasties.
coma protuberans. Curr Oncol Rep. 2006;8:291-296. Ming M, He YY. PTEN: new insights into its regulation and func- J Clin Rheumatol. 2009;15:138-140.
Aydin F, Senturk N, Sabanciler MT, et al. A case of Ferguson-Smith tion in skin cancer. J Invest Dermatol. 2009;129:2109-2112. Arias-Santiago S, Aneiros-Fernandez J, Girón-Prieto MS, et al.
type multiple keratoacanthomas associated with keratoacan- Minicozzi A, Borzellino G, Momo R, et al. Perianal Paget’s disease: Palpable purpura. Cleve Clin J Med. 2010;77:205-206.
thoma centrifugum marginatum: response to oral acitretin. Clin presentation of six cases and literature review. Int J Colorectal Dis. Auerbach PS, ed. Wilderness Medicine. 5th ed. Philadelphia: Mosby;
Exp Dermatol. 2007;32:683-686. 2010;25:1-7. 2007:1262-1286.
Bhawan J. Squamous cell carcinoma in situ in skin: what does it Murphy GF. Dermatopathology. Philadelphia: Saunders; 1995: Ayangco L, Rogers RS 3rd. Oral manifestations of erythema mul-
mean? J Cutan Pathol. 2007;34:953-955. 192-194. tiforme. Dermatol Clin. 2003;21:195-205.
Black APB, Ogg GS. The role of p53 in the immunobiology of Ntomouchtsis A, Vahtsesevanos K, Patrikidou A, et al. Adnexal skin Badea I, Taylor M, Rosenberg A, et al. Pathogenesis and therapeutic
cutaneous squamous cell carcinoma. Clin Exp Immunol. 2003; carcinomas of the face. J Craniofac Surg. 2009;20:134-137. approaches for improved topical treatment in localized sclero-
132:379-384. Odom RB, James WB, Berger TG. Andrews’ Disease of the Skin: derma and systemic sclerosis. Rheumatology. 2009;48:213-221.
Bleeker MCG, Heideman DAM, Snijders PJF, et al. Penile cancer: Clinical Dermatology. 9th ed. Philadelphia: Saunders; 2000: Bandino JP, Wohltmann WE, Bray DW, et al. Naproxen-induced
epidemiology, pathogenesis and prevention. World J Urol. 756-760. generalized bullous fixed drug eruption. Dermatol Online J.
2009;27:141-150. Paradisi A, Abeni D, Rusciani A, et al. Dermatofibrosarcoma pro- 2009;15:4.
Bongiorno MR, Doukaki S, Ferro G, et al. Matrix metalloprotein- tuberans: wide local excision vs. mohs micrographic surgery. Banikazemi M, Bultas J, Waldek S, et al. Agalsidase-beta therapy
ases 2 and 9, and extracellular matrix in Kaposi’s sarcoma. Der- Cancer Treat Rev. 2008;34:728-736. for advanced Fabry disease: a randomized trial. Ann Intern Med.
matol Ther. 2010;23:S33-S36. Richter ON, Petrow W, Wardelmann E, et al. Bowenoid papulosis 2007;146:77-86.
Budd GT. Management of angiosarcoma. Curr Oncol Rep. 2002;4: of the vulva—immunotherapeutical approach with topical Ben-Amitai D, Metzker A, Cohen HA. Pediatric cutaneous masto-
515-519. imiquimod. Arch Gynecol Obstet. 2003;268:333-336. cytosis: a review of 180 patients. Isr Med Assoc J. 2005;7:
Buitrago W, Joseph AK. Sebaceous carcinoma: the great masquer- Rigel DS, Friedman RJ, Dzubow LM, et al. Cancer of the Skin. 320-322.
ader: emerging concepts in diagnosis and treatment. Dermatol Philadelphia: Saunders; 2005. Ben Rayana N, Chahed N, Khochtali S, et al. Ocular ochronosis.
Ther. 2008;21:459-466. Riou-Gotta MO, Fournier E, Danzon A, et al. Rare skin cancer: a A case report. J Fr Ophtalmol. 2008;31:624.
Catena F, Santini D, Di Saverio S, et al. Skin angiosarcoma arising population-based cancer registry descriptive study of 151 con- Bernier J, Booner J, Vermorken JB, et al. Consensus guidelines for
in an irradiated breast: case-report and literature review. Derma- secutive cases diagnosed between 1980 and 2004. Acta Oncol. the management of radiation dermatitis and co-existing acne-like
tol Surg. 2006;32:447-455. 2009;48:605-609. rash in patients receiving radiotherapy plus EGRF inhibitors for
Cox NH, Eedy DJ, Morton CA. Guidelines for management of Schwartz RA, Bridges TM, Butani AK, et al. Actinic keratosis: an the treatment of squamous cell carcinoma of the head and neck.
Bowen’s disease: 2006 update. Br J Dermatol. 2007;156:11-21. occupational and environmental disorder. J Eur Acad Dermatol Ann Oncol. 2008;19:142-149.
Criscione VD, Weinstock MA, Naylor MF, et al. Actinic keratosis: Venereol. 2008;22:606-615. Bieber T, Novak N. Pathogenesis of atopic dermatitis: new devel-
natural history and risk of malignant transformation in the Vet- Shalin SC, Lyle S, Calonje E, et al. Sebaceous neoplasia and the opments. Curr Allergy Asthma Rep. 2009;9:291-294.
erans Affairs Topical Tretinoin Chemoprevention Trial. Cancer. Muir-Torre syndrome: important connections with clinical Blair JE. State-of-the-art treatment of coccidioidomycosis: skin and
2009;115:2523-2530. implications. Histopathology. 2010;56:133-147. soft-tissue infections. Ann N Y Acad Sci. 2007;1111:411-421.
DiLorenzo G. Update on classic Kaposi sarcoma therapy: new look Tai P, Yu E, Assouline A, et al. Management of Merkel cell carci- Boguniewicz M, Leung DY. Recent insights into atopic dermatitis
at an old disease. Crit Rev Oncol/Hematol. 2008;68:242-249. noma with emphasis on small primary tumors: a case series and and implications for management of infectious complications.
Dimitropoulos VA. Dermatofibrosarcoma protuberans. Dermatol review of the current literature. J Drugs Dermatol. 2010;9: J Allergy Clin Immunol. 2010;125:4-13.
Ther. 2008;21:447-451. 105-110. Boissan M, Feger F, Guillosson J, et al. c-Kit and c-kit mutations
Donovan J. Review of the hair follicle origin hypothesis for basal Telfer NR, Clover GB, Morton CA. Guidelines for the manage- in mastocytosis and other hematological diseases. J Leukoc Biol.
cell carcinoma. Dermatol Surg. 2009;35:1311-1323. ment of basal cell carcinoma. Br J Dermatol. 2008;159:35-48. 2000;67:135-148.
Dubina M, Goldenberg G. Viral-associated nonmelanoma skin Vergilis-Kalner IJ, Kriseman Y, Goldberg LH. Keratoacanthomas: Bolognia JL, Jorizzo JL, Rapini RP. Dermatology. 2nd ed. St. Louis:
cancers: a review. Am J Dermatopathol. 2009;31:561-573. overview and comparison between Houston and Minneapolis Mosby; 2008.
Duvic M, Donato M, Dabaja B, et al. Total skin electron beam and experiences. J Drugs Dermatol. 2010;9:117-121. Brahimi N, Routier E, Raison-Peyron N, et al. A three-year-anal-
non-myeloablative allogeneic hematopoietic stem-cell transplan- Weedon D. Skin Pathology. New York: Churchill Livingstone; 1997. ysis of fixed drug eruptions in hospital settings in France. Eur J
tation in advanced mycosis fungoides and Sezary syndrome J Clin Weinberg AS, Ogle CA, Shim EK. Metastatic cutaneous squamous Dermatol. 2010;20:461-464.
Oncol. 2010;28:2365-2372. cell carcinoma: an update. Dermatol Surg. 2007;33:885-899. Bremec T, Demsar J, Luzar B, et al. Longstanding truncal hyper-
Egmond SV, Hoedemaker C, Sinclair R. Successful treatment of Wood AJ, Lappinga PJ, Ahmed I. Hepatocellular carcinoma meta- pigmented patches in a young man. Multiple fixed drug eruption
perianal Bowen’s disease: imiquimod. Int J Dermatol. 2007;46: static to skin: diagnostic utility of antihuman hepatocyte antibody caused by acetaminophen. Clin Exp Dermatol. 2010;35:e56-e57.
318-319. in combination with albumin in situ hybridization. J Cutan Brickman WJ, Huang J, Silverman BL, et al. Acanthosis nigricans
Eisen DB, Michael DJ. Sebaceous lesions and their associated syn- Pathol. 2009;36:262-266. identifies youth at high risk for metabolic abnormalities. J
dromes: part I. J Am Acad Dermatol. 2009;61:549-560. Wu XS, Lonsdorf AS, Hwang ST. Cutaneous T-cell lymphoma: Pediatr. 2010;156:87-92.
Elder DE, Gimotty PA, Guerry D. Cutaneous melanoma: estimat- roles for chemokines and chemokine receptors. J Invest Dermatol. Briley LD, Phillips CM. Cutaneous mastocytosis: a review focusing
ing survival and recurrence risk based on histopathologic fea- 2009;129:1115-1119. on the pediatric population. Clin Pediatr (Phila). 2008;47:
tures. Dermatol Ther. 2005;18:369-385. Yu F, Finn DT, Rogers GS. Microcystic adnexal carcinoma: a rare 757-761.
Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev locally aggressive cutaneous tumor. Am J Clin Oncol. 2010:33: Brockow K. Urticaria pigmentosa. Immunol Allergy Clin North Am.
Cancer. 2008;8:743-754. 196-197. 2004;24:287-316.
Gaertner WB, Hagerman GF, Goldberg SM, et al. Perianal Paget’s Yu W, Tsoukas MM, Chapman SM, et al. Surgical treatment of Buck T, González LM, Lambert WC, et al. Sweet’s syndrome with
disease treated with wide excision and gluteal skin flap recon- dermatofibrosarcoma protuberans: the Dartmouth experience hematologic disorders: a review and reappraisal. Int J Dermatol.
struction: report of a case and review of the literature. Dis Colon and literature review. Ann Plastic Surg. 2008;60:288-293. 2008;47:775-782.
Rectum. 2008;51:1842-1845. Zinzani PL, Ferreri AJM, Cerroni L. Mycosis fungoides. Crit Rev Burrall B. Sweet’s syndrome (acute neutrophilic febrile dermatosis).
Grange JM, Krone B, Stanford JL. Immunotherapy for malignant Oncol/Hematol. 2008;65:172-182. Dermatol Online J. 1999;5:8.
melanoma—tracing Ariadne’s thread through the labyrinth. Eur Zwenzner EM, Kaatz M, Ziemer M. Skin metastasis of ‘nested type’ Buyon JP, Clancy RM, Friedman DM. Cardiac manifestations of
J Cancer. 2009;45:2266-2273. of urothelial carcinoma of the urinary bladder. J Cutan Pathol. neonatal lupus erythematosus: guidelines to management, inte-
Gremel G, Rafferty M, Lau TY, et al. Identification and functional 2006;33:754-755. grating clues from the bench and bedside. Nat Clin Pract Rheu-
validation of therapeutic targets for malignant melanoma. Crit matol. 2009;5:139-148.
Rev Oncol/Hematol. 2009;72:194-214. Section 4: Rashes Camelo-Piragua S, Zambrano E, Pantanowitz L. Langerhans cell
Han A, Ratner D. What is the role of adjuvant radiotherapy in the Abla O, Egeler RM, Weitzman S. Langerhans cell histiocytosis: histiocytosis. Ear Nose Throat J. 2010;89:112-113.
treatment of cutaneous squamous cell carcinoma with perineural current concepts and treatments. Cancer Treat Rev. 2010;36: Cario H, McMullin MF, Pahl HL. Clinical and hematological pre-
invasion? Cancer. 2007;109:1053-1059. 354-359. sentation of children and adolescents with polycythemia vera.
Houben R, Schrama D, Becker JC. Molecular pathogenesis of Ahdout J, Haley JC, Chiu MW. Erythema multiforme during anti- Ann Hematol. 2009;88:713-719.
Merkel cell carcinoma. Exp Dermatol. 2009;18:193-198. tumor necrosis factor treatment for plaque psoriasis. J Am Acad Carlson JA. The histological assessment of cutaneous vasculitis.
Ivan D, Diwan AH, Lazar AJF, et al. The usefulness of p63 detec- Dermatol. 2010;62:874-879. Histopathology. 2010;56:3-23.
tion for differentiating primary from metastatic skin adenocarci- Ahmadi S, Powell FC. Pruritic urticarial papules and plaques of Chang HY, Ridky TW, Kimball AB, et al. Eruptive xanthomas
nomas. J Cutan Pathol. 2008;35:880-881. pregnancy: current status. Australas J Dermatol. 2005;46:53-58. associated with olanzapine use. Arch Dermatol. 2003;139:
Jones B, Oh C, Mangold E, et al. Muir-Torre syndrome: diagnostic Akin C, Valent P, Escribano L. Urticaria pigmentosa and mastocy- 1045-1048.
and screening guidelines. Aust J Dermatol. 2006;47:266-269. tosis: the role of immunophenotyping in diagnosis and determin- Chang KL, Snyder DS. Langerhans cell histiocytosis. Cancer Treat
Kaehler KC, Sondak VK, Schadendorf D, et al. Pegylated interfer- ing response to treatment. Curr Allergy Asthma Rep. 2006;6: Res. 2008;142:383-398.
ons: prospects for the use in the adjuvant and palliative therapy 282-288. Chassaing N, Martin L, Calvas P, et al. Pseudoxanthoma elasticum:
of metastatic melanoma. Eur J Cancer. 2010;46:41-46. Al Hammadi A, Asai Y, Patt ML, et al. Erythema annulare centrifu- a clinical, pathophysiological and genetic update including 11
Kanitakis J. Mammary and extramammary Paget’s disease. J Eur gum secondary to treatment with finasteride. J Drugs Dermatol. novel ABCC6 mutations. J Med Genet. 2005;42:881-892.
Acad Dermatol Venereol. 2007;21:581-590. 2007;6:460-463. Chen YJ, Wu CY, Huang YL, et al. Cancer risks of dermatomyositis
Kirkwood JM, Jukic DM, Averbook BJ, et al. Melanoma in pediat- Ale IS, Maibacht HA. Diagnostic approach in allergic and irritant and polymyositis: a nationwide cohort study in Taiwan. Arthritis
ric, adolescent and young adults. Semin Oncol. 2009;36:419-431. contact dermatitis. Expert Rev Clin Immunol. 2010;6:291-310. Res Ther. 2010;12:R70.
242 THE NETTER COLLECTION OF MEDICAL ILLUSTRATIONS

